Cargando…
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
The prevalence and strength of serological responses mounted toward SARS-CoV-2 proteins other than nucleocapsid (N) and spike (S), which may be of use as additional serological markers, remains underexplored. Using high-content microscopy to assess antibody responses against full-length StrepTagged...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246304/ https://www.ncbi.nlm.nih.gov/pubmed/37346049 http://dx.doi.org/10.1016/j.isci.2023.107056 |
_version_ | 1785055007627804672 |
---|---|
author | Williams, Daniel M. Hornsby, Hailey R. Shehata, Ola M. Brown, Rebecca Gallis, Marta Meardon, Naomi Newman, Thomas A.H. Plowright, Megan Zafred, Domen Shun-Shion, Amber S.M. Hodder, Anthony J. Bliss, Deepa Metcalfe, Andrew Edgar, James R. Gordon, David E. Sayers, Jon R. Nicklin, Martin J. Carroll, Miles Collini, Paul J. Brown, Stephen de Silva, Thushan I. Peden, Andrew A. |
author_facet | Williams, Daniel M. Hornsby, Hailey R. Shehata, Ola M. Brown, Rebecca Gallis, Marta Meardon, Naomi Newman, Thomas A.H. Plowright, Megan Zafred, Domen Shun-Shion, Amber S.M. Hodder, Anthony J. Bliss, Deepa Metcalfe, Andrew Edgar, James R. Gordon, David E. Sayers, Jon R. Nicklin, Martin J. Carroll, Miles Collini, Paul J. Brown, Stephen de Silva, Thushan I. Peden, Andrew A. |
author_sort | Williams, Daniel M. |
collection | PubMed |
description | The prevalence and strength of serological responses mounted toward SARS-CoV-2 proteins other than nucleocapsid (N) and spike (S), which may be of use as additional serological markers, remains underexplored. Using high-content microscopy to assess antibody responses against full-length StrepTagged SARS-CoV-2 proteins, we found that 85% (166/196) of unvaccinated individuals with RT-PCR confirmed SARS-CoV-2 infections and 74% (31/42) of individuals infected after being vaccinated developed detectable IgG against the structural protein M, which is higher than previous estimates. Compared with N antibodies, M IgG displayed a shallower time-dependent decay and greater specificity. Sensitivity for SARS-CoV-2 seroprevalence was enhanced when N and M IgG detection was combined. These findings indicate that screening for M seroconversion may be a good approach for detecting additional vaccine breakthrough infections and highlight the potential to use HCM as a rapidly deployable method to identify the most immunogenic targets of newly emergent pathogens. |
format | Online Article Text |
id | pubmed-10246304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102463042023-06-07 Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy Williams, Daniel M. Hornsby, Hailey R. Shehata, Ola M. Brown, Rebecca Gallis, Marta Meardon, Naomi Newman, Thomas A.H. Plowright, Megan Zafred, Domen Shun-Shion, Amber S.M. Hodder, Anthony J. Bliss, Deepa Metcalfe, Andrew Edgar, James R. Gordon, David E. Sayers, Jon R. Nicklin, Martin J. Carroll, Miles Collini, Paul J. Brown, Stephen de Silva, Thushan I. Peden, Andrew A. iScience Article The prevalence and strength of serological responses mounted toward SARS-CoV-2 proteins other than nucleocapsid (N) and spike (S), which may be of use as additional serological markers, remains underexplored. Using high-content microscopy to assess antibody responses against full-length StrepTagged SARS-CoV-2 proteins, we found that 85% (166/196) of unvaccinated individuals with RT-PCR confirmed SARS-CoV-2 infections and 74% (31/42) of individuals infected after being vaccinated developed detectable IgG against the structural protein M, which is higher than previous estimates. Compared with N antibodies, M IgG displayed a shallower time-dependent decay and greater specificity. Sensitivity for SARS-CoV-2 seroprevalence was enhanced when N and M IgG detection was combined. These findings indicate that screening for M seroconversion may be a good approach for detecting additional vaccine breakthrough infections and highlight the potential to use HCM as a rapidly deployable method to identify the most immunogenic targets of newly emergent pathogens. Elsevier 2023-06-07 /pmc/articles/PMC10246304/ /pubmed/37346049 http://dx.doi.org/10.1016/j.isci.2023.107056 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Williams, Daniel M. Hornsby, Hailey R. Shehata, Ola M. Brown, Rebecca Gallis, Marta Meardon, Naomi Newman, Thomas A.H. Plowright, Megan Zafred, Domen Shun-Shion, Amber S.M. Hodder, Anthony J. Bliss, Deepa Metcalfe, Andrew Edgar, James R. Gordon, David E. Sayers, Jon R. Nicklin, Martin J. Carroll, Miles Collini, Paul J. Brown, Stephen de Silva, Thushan I. Peden, Andrew A. Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
title | Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
title_full | Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
title_fullStr | Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
title_full_unstemmed | Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
title_short | Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
title_sort | establishing sars-cov-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246304/ https://www.ncbi.nlm.nih.gov/pubmed/37346049 http://dx.doi.org/10.1016/j.isci.2023.107056 |
work_keys_str_mv | AT williamsdanielm establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT hornsbyhaileyr establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT shehataolam establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT brownrebecca establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT gallismarta establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT meardonnaomi establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT newmanthomasah establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT plowrightmegan establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT zafreddomen establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT shunshionambersm establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT hodderanthonyj establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT blissdeepa establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT metcalfeandrew establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT edgarjamesr establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT gordondavide establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT sayersjonr establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT nicklinmartinj establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT carrollmiles establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT collinipaulj establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT brownstephen establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT desilvathushani establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy AT pedenandrewa establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy |